Display Settings:

Format

Send to:

Choose Destination

    J Am Chem Soc. 2005 Sep 28;127(38):13164-6.

    A steroid-conjugated contrast agent for magnetic resonance imaging of cell signaling.

    Lee J, Zylka MJ, Anderson DJ, Burdette JE, Woodruff TK, Meade TJ.

    Department of Chemistry, Northwestern University, Evanston, Illinois 60201, USA.

    We have synthesized the first steroid hormone-MR contrast agent conjugate designed to track the cell signaling process upon binding to a gene switch system. The derivative has a high relaxivity and when tested in vitro is active as a progesterone antagonist (RU-486). By combining a transcriptional system and a noninvasive imaging technology, such as MRI, it would be a powerful tool to research the cell signaling pathway in vivo.

    PMID: 16173742 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Progesterone (Prometrium®)

      Progesterone is used as a part of hormone replacement therapy in women who have passed menopause (the change of life) and have not had a hysterectomy (surgery to remove the uterus). Hormone replacement therapy usually in...

    • Mifepristone (Mifeprex®)

      Mifepristone is used alone or in combination with misoprostol (Cytotec) to end an early pregnancy. Early pregnancy means it has been 49 days or less since your last menstrual period began. Mifepristone is in a class of m...